摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-methoxy-1-cyclopropyl-6-fluoro-7-(7-hydroxymethyl-5-aza-spiro[2.4]hept-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 848616-08-0

中文名称
——
中文别名
——
英文名称
8-methoxy-1-cyclopropyl-6-fluoro-7-(7-hydroxymethyl-5-aza-spiro[2.4]hept-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
英文别名
1-Cyclopropyl-6-fluoro-7-[7-(hydroxymethyl)-5-azaspiro[2.4]heptan-5-yl]-8-methoxy-4-oxoquinoline-3-carboxylic acid
8-methoxy-1-cyclopropyl-6-fluoro-7-(7-hydroxymethyl-5-aza-spiro[2.4]hept-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid化学式
CAS
848616-08-0
化学式
C21H23FN2O5
mdl
——
分子量
402.422
InChiKey
QTNPBHFVXUHHPJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    90.3
  • 氢给体数:
    2
  • 氢受体数:
    8

文献信息

  • [EN] QUINOLONE ANTIBACTERIAL AGENTS<br/>[FR] AGENTS ANTIBACTERIENS A BASE DE QUINOLONE
    申请人:WARNER LAMBERT CO
    公开号:WO2005026165A1
    公开(公告)日:2005-03-24
    Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I as disclosed herein can be used in a variety of applications including use as antibacterial agents.
    公开了式I的化合物及其制备方法。进一步公开了制备式I生物活性化合物的方法,以及包括式I化合物的药用可接受组合物。本文公开的式I化合物可用于各种应用,包括用作抗菌剂。
  • Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors
    申请人:Zhuang Linghang
    公开号:US20050010048A1
    公开(公告)日:2005-01-13
    Certain aza- and polyaza-naphthalenyl ketones including certain quinolinyl and naphthyridinyl ketones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment or the delay in the onset of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
    某些氮杂基酮和多氮杂基酮,包括某些喹啉基和啉基酮,被描述为HIV整合酶的抑制剂和HIV复制的抑制剂。这些化合物在预防或治疗HIV感染以及治疗或延缓艾滋病发作方面是有用的,可以作为化合物或药学上可接受的盐,或作为药物组合物中的成分,可选地与其他抗病毒药物、免疫调节剂、抗生素或疫苗结合使用。还描述了治疗或延缓艾滋病发作的方法以及预防或治疗HIV感染的方法。
  • Quinolone antibacterial agents
    申请人:Ellsworth Lee Edmund
    公开号:US20050107423A1
    公开(公告)日:2005-05-19
    Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I as disclosed herein can be used in a variety of applications including use as antibacterial agents.
    本文披露了I式化合物及其制备方法。进一步披露了制备具有生物活性的I式化合物的方法,以及含有I式化合物的药学上可接受的组合物的方法。本文所披露的I式化合物可以用于多种应用,包括用作抗菌剂。
查看更多